Home » FDA’s Office of Pharmaceutical Quality Revs Up Process to Accelerate ANDA Reviews
FDA’s Office of Pharmaceutical Quality Revs Up Process to Accelerate ANDA Reviews
In a preview of how the FDA’s Office of Pharmaceutical Quality will speed approval of generic drugs, the office is rolling out a framework for ANDA filers to respond to minor agency queries involving chemistry, manufacturing and control issues early in the review cycle.
Generic Line
Upcoming Events
-
11Jul
-
18Jul
-
21Oct